As of 2025-09-16, the Relative Valuation of Aldeyra Therapeutics Inc (ALDX) is (7.12) USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.39 USD, the upside of Aldeyra Therapeutics Inc based on Relative Valuation is -232.1%.
The range of the Relative Valuation is (5.68) - (9.35) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 4.3x - 11.1x | 7.7x |
| Forward P/E multiples | 6.7x - 11.6x | 9.1x |
| Fair Price | (5.68) - (9.35) | (7.12) |
| Upside | -205.4% - -273.4% | -232.1% |
| Date | P/E |
| 2025-09-11 | -6.58 |
| 2025-09-10 | -6.56 |
| 2025-09-09 | -6.82 |
| 2025-09-08 | -6.75 |
| 2025-09-05 | -6.58 |
| 2025-09-04 | -6.54 |
| 2025-09-03 | -6.90 |
| 2025-09-02 | -6.80 |
| 2025-08-29 | -6.91 |
| 2025-08-28 | -6.93 |
| 2025-08-27 | -6.92 |
| 2025-08-26 | -6.97 |
| 2025-08-25 | -6.83 |
| 2025-08-22 | -6.88 |
| 2025-08-21 | -6.96 |
| 2025-08-20 | -6.66 |
| 2025-08-19 | -6.63 |
| 2025-08-18 | -6.44 |
| 2025-08-15 | -6.38 |
| 2025-08-14 | -6.27 |
| 2025-08-13 | -6.35 |
| 2025-08-12 | -6.34 |
| 2025-08-11 | -6.21 |
| 2025-08-08 | -6.22 |
| 2025-08-07 | -6.12 |
| 2025-08-06 | -6.18 |
| 2025-08-05 | -6.11 |
| 2025-08-04 | -6.01 |
| 2025-08-01 | -5.69 |
| 2025-07-31 | -5.90 |
| 2025-07-30 | -5.98 |
| 2025-07-29 | -6.02 |
| 2025-07-28 | -6.30 |
| 2025-07-25 | -6.12 |
| 2025-07-24 | -6.44 |
| 2025-07-23 | -6.54 |
| 2025-07-22 | -6.34 |
| 2025-07-21 | -6.38 |
| 2025-07-18 | -6.38 |
| 2025-07-17 | -5.95 |
| 2025-07-16 | -6.11 |
| 2025-07-15 | -5.88 |
| 2025-07-14 | -5.93 |
| 2025-07-11 | -5.50 |
| 2025-07-10 | -5.68 |
| 2025-07-09 | -5.35 |
| 2025-07-08 | -5.12 |
| 2025-07-07 | -5.15 |
| 2025-07-03 | -5.09 |
| 2025-07-02 | -4.73 |